Bank of New York Mellon’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.26M Sell
62,028
-253,480
-80% -$14.4M ﹤0.01% 2537
2026
Q1
$20.3M Buy
315,508
+87,922
+39% +$8.02M ﹤0.01% 1536
2025
Q4
$29.6M Buy
227,586
+64,837
+40% +$8.9M 0.01% 1312
2025
Q3
$17.5M Buy
162,749
+96,390
+145% +$10.5M ﹤0.01% 1616
2025
Q2
$6.13M Buy
66,359
+22,870
+53% +$1.8M ﹤0.01% 2158
2025
Q1
$3.85M Buy
43,489
+2,575
+6% +$223K ﹤0.01% 2361
2024
Q4
$3.14M Buy
40,914
+8,597
+27% +$601K ﹤0.01% 2531
2024
Q3
$1.37M Sell
32,317
-5,601
-15% -$189K ﹤0.01% 2955
2024
Q2
$991K Buy
+37,918
New +$719K ﹤0.01% 3207
2024
Q1
Sell
-10,130
Closed -$27.9K 4324
2023
Q4
$27.9K Hold
10,130
﹤0.01% 4205
2023
Q3
$36.9K Sell
10,130
-2,637
-21% -$14.5K ﹤0.01% 4191
2023
Q2
$76.1K Sell
12,767
-26,306
-67% -$208K ﹤0.01% 4116
2023
Q1
$471K Buy
39,073
+12,913
+49% +$172K ﹤0.01% 3518
2022
Q4
$228K Buy
26,160
+327
+1% +$7.21K ﹤0.01% 3917
2022
Q3
$748K Buy
25,833
+4,539
+21% +$208K ﹤0.01% 3347
2022
Q2
$886K Buy
21,294
+19,799
+1,324% +$1.34M ﹤0.01% 3284
2022
Q1
$151K Hold
1,495
﹤0.01% 4322
2021
Q4
$220K Hold
1,495
﹤0.01% 4241
2021
Q3
$374K Buy
+1,495
New +$513K ﹤0.01% 3955

Other funds holding WGS

Bank of New York Mellon's WGS Position: Q2 2026 in Review

Bank of New York Mellon reduced its GeneDx Holdings (WGS) stake by 80% in Q2 2026, selling an estimated $14.4M and leaving 62,028 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Bank of New York Mellon first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $29.6M in Q4 2025. 128 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Bank of New York Mellon held 62,028 shares of GeneDx Holdings worth $4.26M as of Q2 2026.
  • Bank of New York Mellon sold 253,480 GeneDx Holdings shares in Q2 2026, an estimated $14.4M.
  • GeneDx Holdings made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2537 holding.
  • Bank of New York Mellon first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
  • Bank of New York Mellon's GeneDx Holdings position peaked at $29.6M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.